Bliss GVS Pharma Limited (NSE:BLISSGVS)
India · Delayed Price · Currency is INR 267.95
-1.80 (-0.67%)
May 6, 2026, 3:29 PM IST
Bliss GVS Pharma Market Cap
Bliss GVS Pharma has a market cap or net worth of 28.29 billion as of May 6, 2026. Its market cap has increased by 125.55% in one year.
Market Cap
28.29B
Enterprise Value
27.17B
Revenue
8.68B
Ranking
n/a
PE Ratio
25.93
Stock Price
267.95
Market Cap Chart
Since January 11, 2002, Bliss GVS Pharma's market cap has increased from 10.05M to 28.29B, an increase of 281,370.68%. That is a compound annual growth rate of 38.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 28.53B | 64.95% |
| Dec 31, 2025 | 17.30B | -0.33% |
| Dec 31, 2024 | 17.35B | 33.41% |
| Dec 29, 2023 | 13.01B | 72.15% |
| Dec 30, 2022 | 7.56B | -29.58% |
| Dec 31, 2021 | 10.73B | -48.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innova Captab | 49.85B |
| Sun Pharma Advanced Research Company | 45.43B |
| RPG Life Sciences | 38.41B |
| Orchid Pharma | 31.82B |
| Solara Active Pharma Sciences | 24.14B |
| Indoco Remedies | 19.87B |
| Windlas Biotech | 18.43B |
| Sakar Healthcare | 14.01B |